Grifols SA (GIKLY) stock
GIKLYOTCPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GRFS
$5.55+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.91BP/E 4.2Yield –
Grifols total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Grifols's total debt was €2.16B at Dec 31, 2025. For fiscal 2025 it was €2.16B, down 7.7% from the year before. The highest annual figure on record is €5.17B in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €2.16B | -7.7% |
| FY2024 | Dec 31, 2024 | €2.34B | -45.9% |
| FY2023 | Dec 31, 2023 | €4.32B | +7.0% |
| FY2022 | Dec 31, 2022 | €4.04B | +9.0% |
| FY2021 | Dec 31, 2021 | €3.71B | +7.0% |
| FY2020 | Dec 31, 2020 | €3.46B | -6.0% |
| FY2019 | Dec 31, 2019 | €3.69B | -28.6% |
| FY2018 | Dec 31, 2018 | €5.17B | +2.2% |
| FY2017 | Dec 31, 2017 | €5.05B | +4732.3% |
| FY2016 | Dec 31, 2016 | €104.56M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | €2.16B | -41.8% |
| Q4 FY2024 | Dec 31, 2024 | €2.34B | -32.5% |
| Q4 FY2023 | Dec 31, 2023 | €4.32B | +17.2% |
| Q4 FY2022 | Dec 31, 2022 | €4.04B | -21.8% |
| Q4 FY2021 | Dec 31, 2021 | €3.71B | -26.6% |
| Q4 FY2020 | Dec 31, 2020 | €3.46B | +3213.7% |
| Q4 FY2019 | Dec 31, 2019 | €3.69B | – |
| Q4 FY2018 | Dec 31, 2018 | €5.17B | – |
| Q4 FY2017 | Dec 31, 2017 | €5.05B | – |
| Q4 FY2016 | Dec 31, 2016 | €104.56M | – |
See a number that looks wrong?